Global model for oncology condition with a complex patient flow
A large global pharmaceutical company wanted to better understand the product potential of a late-stage, highly targeted pipeline drug candidate for immunotherapy. This drug was indicated for a complex, underserved therapeutic condition.
Viscadia was asked to design and build a custom forecast model spanning all global regions and accommodating key therapeutic and commercial drivers of product performance.
Client gained unprecedented buy-in from 15 regional counterparts and global HQ
CHALLENGES
Complex patient flow and treatment paradigm
- Multiple indications and lines of therapy constituting an interlinked treatment paradigm, with regional variations in physician preferences and demographic nuances
Staggered launches,Non-promoted usage
- Underserved therapy area combined with multiple indications and staggered launches, leading to significant potential in non-promoted usage
Cross-functional stakeholder management
- Regional stakeholders from 15 participating geographies
- Multiple third-party vendor/partners conducting supporting research
- Senior management at global HQ responsible for global forecast
APPROACH
Executed in-depth therapy-area research
- Assessed therapy-area nuances, clinical and commercial drivers of product usage, and shift in treatment paradigms driven by imminent pipeline approvals
Conducted analogue research
- Identified and evaluated uptake performances of recent key launches to drive uptake assumptions
Supported design of primary market research (PMR)
- Identified relevant analogues to develop a perspective on pricing and implications of the ensuing access constraints on product uptake
Developed forecast platform
- Customized platform for the product opportunity that allowed for dynamic, comprehensive evaluation of key performance drivers, and enabled scenario comparison and contrasting
OUTCOMES
End deliverables
- Standard patient flow design harmonizing variations and commonalities in forecasting approach across global regions
- Forecast platform with a comprehensive set of output views and summaries addressing cross-functional stakeholders
- Efficient interface to facilitate easy aggregation of forecast results across global regions
- Geography-specific thought leadership on prioritizing action plan leading up to launch
Key highlights
- Successfully collaborated and worked harmoniously alongside multiple third-party vendors
- Delivered support and leadership to stakeholders from 15 global regions across multiple time zones
- Conducted live workshops to drive adoption and support for new forecasting platform among multiple stakeholders
Impact
- U.S. leadership gained unprecedented buy-in from all regional counterparts and Global HQ on asset potential
- Client successfully moved the asset to Phase III of clinical trials following global opportunity assessment
- Established an end-to-end forecasting process which eventually defined best practices across multiple pipeline assets
